Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q7RUX3

Entry ID Method Resolution Chain Position Source
AF-Q7RUX3-F1 Predicted AlphaFoldDB

No variants for Q7RUX3

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q7RUX3

No associated diseases with Q7RUX3

2 regional properties for Q7RUX3

Type Name Position InterPro Accession
domain RNA recognition motif domain 239 - 312 IPR000504
domain Slt11, RNA recognition motif 237 - 310 IPR034356

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
post-mRNA release spliceosomal complex A spliceosomal complex that is formed following the release of the spliced product from the post-spliceosomal complex and contains the excised intron and three snRNPs, including U5.
Prp19 complex A protein complex consisting of Prp19 and associated proteins that is involved in the transition from the precatalytic spliceosome to the activated form that catalyzes step 1 of splicing, and which remains associated with the spliceosome through the second catalytic step. It is widely conserved, found in both yeast and mammals, though the exact composition varies. In S. cerevisiae, it contains Prp19p, Ntc20p, Snt309p, Isy1p, Syf2p, Cwc2p, Prp46p, Clf1p, Cef1p, and Syf1p.
U2-type catalytic step 1 spliceosome A spliceosomal complex that is formed by the displacement of the U1 and U4 snRNPs from the precatalytic spliceosome; the U2, U5 and U6 snRNPs remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the U2, and U5 and U6 snRNPs.
U2-type catalytic step 2 spliceosome A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs.

2 GO annotations of molecular function

Name Definition
pre-mRNA binding Binding to a pre-messenger RNA (pre-mRNA), an intermediate molecule between DNA and protein that may contain introns and, at least in part, encodes one or more proteins. Introns are removed from pre-mRNA to form a mRNA molecule.
U6 snRNA binding Binding to a U6 small nuclear RNA (U6 snRNA).

2 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
RNA splicing The process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MPPQIKHDLN RSGWEATDFP SVCENCLPEN PYVKMLKEDY GAECKLCTRP FTVFSWAADR
70 80 90 100 110 120
AHARKKRTNI CLTCARLKNA CQCCILDLQF GLPIIIRDKA LELVAPGPQS EINREYFAQN
130 140 150 160 170 180
NERAIEEGRA GVEEYEKADE KARELLRRLA QSKPYFRKGR EVDEEGNPVN GSSSGAGRAT
190 200 210 220 230 240
GGNPAVGAGV GGVGPIRTRD SRAAAAAGAR PGGGRRPNAA PAPPPGPKDW LPPADKSIMS
250 260 270 280 290 300
LFVTGIEDDL PEFKIRDFFK AFGKIKSLVV SHMSHAAFVN YETREAAEKA SAECKGRAVI
310 320 330 340 350 360
AGCPLRVRWS VPKALGTMNK EQRSEMLRDG RSAFGSGQKT GGQKAIGGQN AQGGASGAQK
370 380
DDASNLTIAA PPGAADVQYA SLSGN